NeurologyLive® Friday 5 — June 10, 2022

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending June 10, 2022.

Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: State of Stem Cell Transplantation for Multiple Sclerosis

Jeffrey Cohen, MD, shared his perspective on the current use and study of stem cells for the treatment of multiple sclerosis, which he covered in the CMSC Presidential Lecture at the 2022 annual meeting.

2: Mind Moments™ Special Episode: Aducanumab and Anti-Amyloid-ß, One Year Later

Mind Moments™, a podcast from NeurologyLive®, brings you a special episode recap of aducanumab's journey from discovery to present, ahead of the June 2022 issue's in-depth cover story on the topic.

3: NeuroVoices: Jens Kuhle, MD, on Evobrutinib’s Association With Neurofilament Light Levels

The head of the MS Center at the University of Basel discussed an analysis presented at Consortium of MS Center’s Annual Meeting, focusing on the effects of BTK inhibitor evobrutinib on neurofilament light levels.

4: Peer Exchange: Multidisciplinary Management of OFF Episodes in PD

In Episode 10 of the NeurologyLive® Peer Exchange, "Considerations for the Maintenance of ON Time in Parkinson Disease," experts in movement disorders share the importance of multidisciplinary team collaboration for the management of OFF episodes and shared-decision making for treating Parkinson disease.

5: Lingering Challenges With Assessing, Treating Sleep Problems in Alzheimer Disease: Ruth Benca, MD, PhD

The professor and chair of Psychiatry & Human Behavior at Wake Forest School of Medicine discussed the need for improved tools to evaluate and treat sleep disorders in patients with Alzheimer disease.

—————————————————